000 01338nam  2200337zi 4500
0019.889064
003CaOODSP
00520221107172155
006m     o  d f      
007cr |n|||||||||
008200708s1991    oncd||| ob   f00| 0|eng d
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aRG43-47/1991E-PDF
1001 |aDuncan, Ross, |eauthor.
24510|aR & D expenditures in Canada and other countries / |cRoss Duncan, Dave Blaker.
264 1|a[Ottawa] : |bConsumer and Corporate Affairs Canada, |c[1991]
300 |a1 online resource (ii, 17 pages) : |bcharts
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aDigitized edition from print [produced by Innovation, Science and Economic Development Canada].
500 |a"Draft."
504 |aIncludes bibliographical references (page 11).
650 0|aPharmaceutical industry|xResearch|zCanada.
650 0|aDrugs|xResearch|zCanada|xCosts.
650 0|aIndustrie pharmaceutique|xRecherche|zCanada|xCoût.
650 0|aMédicaments|xRecherche|zCanada.
7101 |aCanada. |bConsumer and Corporate Affairs, |eissuing body.
85640|qPDF|s627 KB|uhttps://publications.gc.ca/collections/collection_2022/isde-ised/RG43-47-1991-eng.pdf